← back to search

Yingnan Zhang

Georgia Institute of Technology · US
Area of research
Radiology, Nuclear Medicine and Imaging · Cardiology and Cardiovascular Medicine
Research interest
Research focused on Cell biology and Cancer research, with related work in Wnt signaling pathway, Proteasome, Frizzled. Notable publications include 'Targeted degradation via direct 26S proteasome recruitment', 'A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells', and 'Senescent cells perturb intestinal stem cell differentiation through Ptk7 induced noncanonical Wnt and YAP signaling'.
h-index
citations
371
works
11
NIH funding
primary concept
email

Recent publications

ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma
Cancer Letters 2024cited by 6position: middledoi
STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration
American Journal of Cancer Research 2024cited by 3position: firstdoi
Senescent cells perturb intestinal stem cell differentiation through Ptk7 induced noncanonical Wnt and YAP signaling
Nature Communications 2023cited by 60position: middledoi
Targeted degradation via direct 26S proteasome recruitment
Nature Chemical Biology 2022cited by 108position: middledoi
Prevention of distal stent graft-induced new entry after endovascular repair for type B aortic dissection: A retrospective cohort study
Journal of Thoracic and Cardiovascular Surgery 2022cited by 14position: middledoi
IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription
Aging 2020cited by 14position: middledoi
lncRNA CASC9 regulates cell migration and invasion in hemangioma endothelial cells by targeting miR-125a-3p/Nrg1
OncoTargets and Therapy 2019cited by 22position: middledoi
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
Nature Chemical Biology 2018cited by 82position: middledoi
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
Nature Chemical Biology 2018cited by 1position: middledoi
Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV)
Vascular Medicine 2015cited by 26position: middledoi
Calcium-Independent Inhibition of PCSK9 by Affinity-Improved Variants of the LDL Receptor EGF(A) Domain
Journal of Molecular Biology 2012cited by 35position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Zhanfeng Sun · Harbin Medical University3 papers (2015–2022)Aaron H. Nile · Texas A&M University3 papers (2018–2023) · 3 papers (2018–2023)Wayne J. Fairbrother · Amgen (United States)3 papers (2018–2022)Rami N. Hannoush · National University of Singapore3 papers (2018–2023)Lijuan Zhou · South China Agricultural University3 papers (2012–2022)Zora Modrušan · Genetic Technologies (Australia)3 papers (2018–2023)Yue Fu · Hangzhou Normal University2 papers (2018–2018)Lijuan Zhou · Kunming University of Science and Technology2 papers (2018–2023)Weiliang Jiang · South China Agricultural University2 papers (2015–2020)Frédéric J. de Sauvage · Gene Therapy Laboratory2 papers (2018–2018) · 2 papers (2018–2018)Weiru Wang · Chongqing University2 papers (2018–2018)Stéphane Angers · University of Toronto2 papers (2018–2018)Christopher M. Koth · Gene Therapy Laboratory2 papers (2018–2018)Felipe de Sousa e Melo · Amgen (United States)2 papers (2018–2018)Susmith Mukund · Amgen (United States)2 papers (2018–2018)Robert Piskol · Gene Therapy Laboratory2 papers (2018–2018)Weiliang Jiang · Harbin Medical University2 papers (2019–2022) · 2 papers (2018–2018)